CN Stock MarketDetailed Quotes

Luoxin Pharmaceuticals Group Stock (002793)

Watchlist
  • 4.80
  • +0.12+2.56%
Market Closed May 20 15:00 CST
5.22BMarket Cap-19.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Luoxin Pharmaceuticals Group Stock (002793) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Digestive system1.08B47.41%
Antibiotics568.44M25.00%
Other classes244.05M10.73%
Agent product203.56M8.95%
Respiratory system120.46M5.30%
Other business59.09M2.60%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry2.01B88.45%
Pharmaceutical commerce203.56M8.95%
Other business59.09M2.60%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region922.29M40.57%
North China294.07M12.93%
Southwest area242.1M10.65%
Northeast area212.46M9.35%
Central China197.33M8.68%
South China168.73M7.42%
Northwest region124.16M5.46%
Other business59.09M2.60%
Other areas53.24M2.34%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.